comparator
Showing 1 - 16 of 16
Overactive Bladder(OAB) Trial in Seoul (JLP-2002, Comparator)
Completed
- Overactive Bladder(OAB)
- JLP-2002
- Comparator
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 10, 2021
Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections, Staphylococcal Skin Infections Trial in Worldwide
Recruiting
- Methicillin-Resistant Staphylococcus Aureus
- +2 more
- Dalbavancin single dose
- +2 more
-
Mobile, Alabama
- +26 more
Jan 27, 2023
Pulmonary Disease, Chronic Obstructive Trial in Manchester (Glycopyrrolate, Comparator)
Completed
- Pulmonary Disease, Chronic Obstructive
- Glycopyrrolate
- Comparator
-
Manchester, United KingdomMedicines Evaluation Unit Ltd.
Oct 28, 2021
Mid Face Volume Loss Trial in Beijing (experimental, comparator)
Completed
- Mid Face Volume Loss
- experimental
- comparator
-
Beijing, ChinaBeijing Hopsital
Mar 17, 2021
Lesion in Body Region, CNS Lesion Trial in Japan (Gadopiclenol, Comparator)
Recruiting
- Lesion in Body Region
- CNS Lesion
- Gadopiclenol
- Comparator
-
Aichi, Japan
- +27 more
Aug 28, 2023
Influenza Trial (Adjuvanted SARS-CoV-2 Subunit vaccine (aCoV2), Comparator)
Withdrawn
- Influenza
- Adjuvanted SARS-CoV-2 Subunit vaccine (aCoV2)
- Comparator
- (no location specified)
Mar 19, 2021
Respiratory Infection Trial in Korea, Republic of (CKD-497 200mg, CKD-497 300mg, CKD-497 )
Completed
- Respiratory Infection
- CKD-497 200mg
- +4 more
-
Ulsan, Dong-gu, Korea, Republic of
- +14 more
Feb 5, 2020
Osteomyelitis Trial in Cherkasy (Dalbavancin, Comparator)
Completed
- Osteomyelitis
- Dalbavancin
- Comparator
-
Cherkasy, UkraineAllergan Investigative Site 001
Dec 11, 2018
Peripheral Artery Disease (PAD) Trial in United States (Ticagrelor, Comparator)
Terminated
- Peripheral Artery Disease (PAD)
- Ticagrelor
- Comparator
-
Daytona Beach, Florida
- +9 more
Jun 21, 2017
Peripheral Artery Disease Trial (platelet (P2Y12) reaction units, ticagrelor, Comparator)
Unknown status
- Peripheral Artery Disease
- platelet (P2Y12) reaction units
- +2 more
- (no location specified)
May 3, 2016
A 2-Month Safety Follow-Up Trial
Completed
- Type 1 Diabetes
- Type 2 Diabetes
- Technosphere Insulin Inhalation Powder
- Comparator
-
Birmingham, Alabama
- +149 more
Dec 1, 2014